VIDEO: Dupilumab lowers IgE levels in AD patients regardless of dosing interval
- Jeremy Visser
- Oct 11, 2023
- 1 min read
According to a recent study, dupilumab successfully decreases immunoglobulin E (IgE) serum levels in atopic dermatitis (AD) patients regardless of dosing interval.
Commentaires